Telix Pharmaceuticals Limited (ASX:TLX) Directors Insider Transactions



The Directors and Chief Executives of Telix Pharmaceuticals Limited (ASX:TLX) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Telix Pharmaceuticals Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Telix Pharmaceuticals Limited to the ASX stock exchange.

An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

Telix Pharmaceuticals Limited Directors/Insider Transactions Activity

List of Insider trades activity from Telix Pharmaceuticals Limited (TLX).

Date Director Director's Title Shares Value Note
05 Nov 2025 Behrenbruch (Christian P. Ph.D.) Chief Executive Officer 100,708 - -
21 May 2025 McCann (Harry Kevin) Former 1,120,000 - -
05 Mar 2025 McDonald (Marie) Independent Non-Executive Director 3,719 63,389 Purchase at price 17.04 per share.
05 Mar 2025 Olson (Tiffany) Independent Non-Executive Director 11,315 202,321 Purchase at price 17.88 per share.
27 Feb 2025 Behrenbruch (Christian P. Ph.D.) Chief Executive Officer 2,000,000 36,774,600 Sale at price 18.39 per share.
27 Feb 2025 McCann (Harry Kevin) Chairman of the Board 30,000 569,010 Sale at price 18.97 per share.
17 Oct 2024 Kluge (Andreas) Former 22,675,000 - -
17 May 2024 Behrenbruch (Christian P. Ph.D.) Chief Executive Officer 100,708 - -
17 May 2024 Cade (David) Divisional Officer 373,133 - -
17 May 2024 Valeix (R) Chief Commercial Officer 75,000 - -